Identification of a gene expression signature associated with pediatric AML prognosis.

Abstract:

:Most patients with acute myeloid leukemia (AML) enter complete remission (CR) after treatment with chemotherapy, but a large number of them experience relapse with resistant disease. To identify genes that are associated with their prognoses, we analyzed gene expression in 54 pediatric patients with AML using an oligonucleotide microarray that contained 12 566 probe sets. A supervised approach using the Student t test selected a prognostic set of 35 genes, some of which are associated with the regulation of cell cycle and apoptosis. Most of these genes had not previously been reported to be associated with prognosis and were not correlated with morphologically classified French-American-British (FAB) subtypes or with karyotypes. These results indicate the existence of prognosis-associated genes that are independent of cell lineage and cytogenetic abnormalities, and they can provide therapeutic direction for individual risk-adapted therapy for pediatric AML patients.

journal_name

Blood

journal_title

Blood

authors

Yagi T,Morimoto A,Eguchi M,Hibi S,Sako M,Ishii E,Mizutani S,Imashuku S,Ohki M,Ichikawa H

doi

10.1182/blood-2003-02-0578

subject

Has Abstract

pub_date

2003-09-01 00:00:00

pages

1849-56

issue

5

eissn

0006-4971

issn

1528-0020

pii

2003-02-0578

journal_volume

102

pub_type

杂志文章

相关文献

BLOOD文献大全
  • Pneumococcal conjugate vaccine provides early protective antibody responses in children after related and unrelated allogeneic hematopoietic stem cell transplantation.

    abstract::Following allogeneic hematopoietic stem cell transplantation (alloHSCT), children are at risk of life-threatening pneumococcal infections. Whereas vaccination with polysaccharide vaccines fails to elicit protective immunity in most alloHSC transplant recipients, pneumococcal conjugate vaccines may effectively prevent ...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1182/blood-2006-06-032284

    authors: Meisel R,Kuypers L,Dirksen U,Schubert R,Gruhn B,Strauss G,Beutel K,Groll AH,Duffner U,Blütters-Sawatzki R,Holter W,Feuchtinger T,Grüttner HP,Schroten H,Zielen S,Ohmann C,Laws HJ,Dilloo D,Impfung von Kindern nach allog

    更新日期:2007-03-15 00:00:00

  • Minimal region of loss at 13q14 in B-cell chronic lymphocytic leukemia.

    abstract::Allelic loss at nonrandom chromosomal sites is thought to mark the position of tumor suppressor genes involved in the pathogenesis and progression of human malignancies. Solid tumors in particular have been found to harbor multiple genetic changes resulting in loss of function mutations. Tumor suppressor genes have al...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Bullrich F,Veronese ML,Kitada S,Jurlander J,Caligiuri MA,Reed JC,Croce CM

    更新日期:1996-10-15 00:00:00

  • Crystal structure and functional interpretation of the erythrocyte spectrin tetramerization domain complex.

    abstract::As the principal component of the membrane skeleton, spectrin confers integrity and flexibility to red cell membranes. Although this network involves many interactions, the most common hemolytic anemia mutations that disrupt erythrocyte morphology affect the spectrin tetramerization domains. Although much is known cli...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-01-261396

    authors: Ipsaro JJ,Harper SL,Messick TE,Marmorstein R,Mondragón A,Speicher DW

    更新日期:2010-06-10 00:00:00

  • Maternal genomic neutrophil FcRIII deficiency leading to neonatal isoimmune neutropenia.

    abstract::The healthy mother of a child with transient immune neutropenia was found to be "NA-null." The mother's neutrophils did not react with anti-NA1 and anti-NA2 antibodies (polyclonal human alloantibodies and mouse monoclonal antibodies). A healthy donor was discovered during routine neutrophil antigen typing whose neutro...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Huizinga TW,Kuijpers RW,Kleijer M,Schulpen TW,Cuypers HT,Roos D,von dem Borne AE

    更新日期:1990-11-15 00:00:00

  • Low NAD(P)H:quinone oxidoreductase activity is associated with increased risk of leukemia with MLL translocations in infants and children.

    abstract::An inactivating polymorphism at position 609 in the NAD(P)H:quinone oxidoreductase 1 gene (NQO1 C609T) is associated with an increased risk of adult leukemia. A small British study suggested that NQO1 C609T was associated with an increased risk of infant leukemias with MLL translocations, especially infant acute lymph...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2001-12-0264

    authors: Smith MT,Wang Y,Skibola CF,Slater DJ,Lo Nigro L,Nowell PC,Lange BJ,Felix CA

    更新日期:2002-12-15 00:00:00

  • Beyond HLA: the significance of genomic variation for allogeneic hematopoietic stem cell transplantation.

    abstract::The last 2 years have seen much excitement in the field of genetics with the identification of a formerly unappreciated level of "structural variation" within the normal human genome. Genetic structural variants include deletions, duplications, and inversions in addition to the recently discovered, copy number variant...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2006-06-030858

    authors: Mullally A,Ritz J

    更新日期:2007-02-15 00:00:00

  • Enhanced myeloid progenitor cell cycling and apoptosis in mice lacking the chemokine receptor, CCR2.

    abstract::Chemokines regulate hematopoiesis in part by influencing the proliferative status of myeloid progenitor cells (MPC). Human MCP-1/murine JE, a myelosuppressive chemokine, specifically binds C-C chemokine receptor 2 (CCR2). Transgenic mice containing a targeted disruption in CCR2 that prevents expression of CCR2 mRNA an...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Reid S,Ritchie A,Boring L,Gosling J,Cooper S,Hangoc G,Charo IF,Broxmeyer HE

    更新日期:1999-03-01 00:00:00

  • Venous thrombosis risk associated with plasma hypofibrinolysis is explained by elevated plasma levels of TAFI and PAI-1.

    abstract::Elevated plasma clot lysis time (CLT) increases risk of venous and arterial thrombosis. It is unclear which fibrinolytic factors contribute to thrombosis risk. In 743 healthy control subjects we investigated determinants of CLT. By comparison with 770 thrombosis patients, we assessed plasma levels of fibrinolytic prot...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-02-267740

    authors: Meltzer ME,Lisman T,de Groot PG,Meijers JC,le Cessie S,Doggen CJ,Rosendaal FR

    更新日期:2010-07-08 00:00:00

  • The future of anti-CD20 monoclonal antibodies: are we making progress?

    abstract::The anti-CD20 monoclonal antibody (mAb) rituximab has revolutionized the treatment of B-cell malignancies. This unprecedented success has not only substantially changed the mindset of the clinical community about the ability of mAb to improve outcomes but has catalyzed the interest in the pharmaceutical industry to de...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-07-298356

    authors: Alduaij W,Illidge TM

    更新日期:2011-03-17 00:00:00

  • Detection of the carrier state for classic hemophilia using an enzyme-linked immunosorbent assay (ELISA).

    abstract::A high proportion of carriers of classic hemophilia can be identified in the laboratory because, in comparison to normal women, the concentration of antigens related to antihemophilic factor (AHF, factor VIII) that are detected in their plasma by heterologous antiserum (factor VIIIR:Ag) is relatively higher than the t...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Fishman DJ,Jones PK,Menitove JE,Ratnoff OD,Everson B

    更新日期:1982-06-01 00:00:00

  • The CXCR7 chemokine receptor promotes B-cell retention in the splenic marginal zone and serves as a sink for CXCL12.

    abstract::The splenic marginal zone (MZ) is comprised of specialized populations of B cells, dendritic cells, and macrophages that are uniquely arrayed outside the white pulp follicles to screen the blood for bacterial and other particulate Ags. Mechanisms responsible for MZ B-cell formation, localization, retention, and functi...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-03-343608

    authors: Wang H,Beaty N,Chen S,Qi CF,Masiuk M,Shin DM,Morse HC 3rd

    更新日期:2012-01-12 00:00:00

  • Role of cytokines in leukemic type growth of myelodysplastic CD34+ cells.

    abstract::The clonal growth of progenitor cells from myelodysplastic syndromes (MDS) can be subdivided into four growth patterns: (1) normal, (2) no growth or low plating efficiency, (3) low colony and high cluster number, and (4) normal or high colony number with a large number of clusters. The former two (1 and 2) can be refe...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Sawada K,Ieko M,Notoya A,Tarumi T,Koizumi K,Kitayama S,Nishio H,Fukada Y,Yasukouchi T,Yamaguchi M,Katoh S,Koike T

    更新日期:1996-07-01 00:00:00

  • Cytarabine plus idarubicin or daunorubicin as induction and consolidation therapy for previously untreated adult patients with acute myeloid leukemia.

    abstract::The purpose of this study was to determine the relative merits of idarubicin and daunorubicin in acute myeloid leukemia (AML) therapy. Thirty-two sites provided 214 previously untreated adults with AML aged 15 years or more who were randomized to receive for induction therapy cytarabine 100 mg/m2/d as a continuous 7-d...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: Wiernik PH,Banks PL,Case DC Jr,Arlin ZA,Periman PO,Todd MB,Ritch PS,Enck RE,Weitberg AB

    更新日期:1992-01-15 00:00:00

  • Second cancers and late toxicities after treatment of aggressive non-Hodgkin lymphoma with the ACVBP regimen: a GELA cohort study on 2837 patients.

    abstract::The survival of patients with aggressive non-Hodgkin lymphoma (NHL) is increasing, but the incidence of secondary cancer and late toxicity is poorly defined for those treated with cyclophosphamide-hydroxydaunomycin/doxorubicin-Oncovin-prednisone (CHOP)-like chemotherapy. From February 1984 to January 1998, 2837 patien...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-04-1124

    authors: André M,Mounier N,Leleu X,Sonet A,Brice P,Henry-Amar M,Tilly H,Coiffier B,Bosly A,Morel P,Haioun C,Gaulard P,Reyes F,Gisselbrecht C,Groupe D'Etude Des Lymphomes De L'Adulte.

    更新日期:2004-02-15 00:00:00

  • Development of a lethal mast cell disease in mice reconstituted with bone marrow cells expressing the v-erbB oncogene.

    abstract::An animal model for malignant mastocytosis is described in mice reconstituted with bone marrow cells expressing the v-erbB oncogene. The lethal mast cell disease is characterized by massive infiltration of bone marrow, spleen, and several other visceral organs by connective tissue mast cells, which normally reside in ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: von Rüden T,Kandels S,Radaszkiewicz T,Ullrich A,Wagner EF

    更新日期:1992-06-15 00:00:00

  • Presence of functional dendritic cells in patients chronically infected with hepatitis C virus.

    abstract::The absence of expanded numbers of hepatitis C virus (HCV)-reactive CD8(+) T lymphocytes (CTLs) in patients chronically infected with HCV has led to the investigation of dendritic cell (DC) function in this population as a potential cause for this defect. Several studies have shown evidence for impaired monocyte-deriv...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-04-1339

    authors: Longman RS,Talal AH,Jacobson IM,Albert ML,Rice CM

    更新日期:2004-02-01 00:00:00

  • N-Ras(G12D) induces features of stepwise transformation in preleukemic human umbilical cord blood cultures expressing the AML1-ETO fusion gene.

    abstract::AML1-ETO (AE) is a fusion product of t(8;21) observed in 40% French-American-British M2 type of acute myeloid leukemia (AML). Clinical data suggest that Ras mutation is a frequent cooperating event in t(8;21) AML. Whether constitutively active Ras promotes leukemogenesis on the t(8;21) background has not been demonstr...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-01-264119

    authors: Chou FS,Wunderlich M,Griesinger A,Mulloy JC

    更新日期:2011-02-17 00:00:00

  • Self-antigen presentation by mouse B cells results in regulatory T-cell induction rather than anergy or clonal deletion.

    abstract::Multiple mechanisms operate to ensure T-cell tolerance toward self-antigens. Three main processes have been described: clonal deletion, anergy, and deviation to CD4(+) regulatory T cells (Tregs) that suppress autoreactive T cells that have escaped the first 2 mechanisms. Although it is accepted that dendritic cells (D...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-02-336115

    authors: Morlacchi S,Soldani C,Viola A,Sarukhan A

    更新日期:2011-07-28 00:00:00

  • Comparison of the ankyrin (AC)n microsatellites in genomic DNA and mRNA reveals absence of one ankyrin mRNA allele in 20% of patients with hereditary spherocytosis.

    abstract::Combined deficiency of ankyrin and spectrin represents the most common biochemical abnormality in hereditary spherocytosis (HS). To examine whether a decrease in ankyrin mRNA represents a frequent cause of this type of HS, we took advantage of the reported (AC)n microsatellite polymorphism in the 3' untranslated regio...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Jarolim P,Rubin HL,Brabec V,Palek J

    更新日期:1995-06-01 00:00:00

  • Histamine induces interleukin-8 secretion by endothelial cells.

    abstract::It has been shown that histamine induces early changes on endothelial cells (EC), such as a transient expression of P-selectin and secretion and/or surface expression of early mediators (eg, prostacyclin [PG1(2)], platelet-activating factor [PAF], and leukotriene B4 [LTB4]). However, delayed effects of histamine on EC...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Jeannin P,Delneste Y,Gosset P,Molet S,Lassalle P,Hamid Q,Tsicopoulos A,Tonnel AB

    更新日期:1994-10-01 00:00:00

  • Factor VIII/von Willebrand factor in subendothelium mediates platelet adhesion.

    abstract::The present studies were undertaken to determine whether factor VIII/von Willebrand factor (vWF) present in the vessel wall (in addition to that in plasma) may mediate the attachment of platelets to subendothelium. Subendothelium from everted rabbit aorta was exposed to human citrated blood flowing through an annular ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Turitto VT,Weiss HJ,Zimmerman TS,Sussman II

    更新日期:1985-04-01 00:00:00

  • Serum levels of substance P are elevated in patients with sickle cell disease and increase further during vaso-occlusive crisis.

    abstract::As a mediator of neurogenic inflammation and pain, we hypothesized that levels of the neuropeptide Substance P (SP) would be elevated in patients with sickle cell disease (SCD) with vaso-occlusive pain crisis. SP is a known stimulator of tumor necrosis factor-alpha (TNF-alpha) release and a promoter of interleukin-8 (...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Michaels LA,Ohene-Frempong K,Zhao H,Douglas SD

    更新日期:1998-11-01 00:00:00

  • Expression of Pitx2 in stromal cells is required for normal hematopoiesis.

    abstract::Although the expression of Pitx2, a bicoid family homeodomain transcription factor, is highly regulated during hematopoiesis, its function during this process was not documented; we thus studied hematopoiesis in Pitx2-null mice. We found that Pitx2(-/-) embryos display hypoplastic livers with reduced numbers of hemato...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-02-0529

    authors: Kieusseian A,Chagraoui J,Kerdudo C,Mangeot PE,Gage PJ,Navarro N,Izac B,Uzan G,Forget BG,Dubart-Kupperschmitt A

    更新日期:2006-01-15 00:00:00

  • Bioengineering of coagulation factor VIII for improved secretion.

    abstract::Factor VIII (FVIII) functions as a cofactor within the intrinsic pathway of blood coagulation. Quantitative or qualitative deficiencies of FVIII result in the inherited bleeding disorder hemophilia A. Expression of FVIII (domain structure A1-A2-B-A3-C1-C2) in heterologous mammalian systems is 2 to 3 orders of magnitud...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-10-3591

    authors: Miao HZ,Sirachainan N,Palmer L,Kucab P,Cunningham MA,Kaufman RJ,Pipe SW

    更新日期:2004-05-01 00:00:00

  • Regulation of ITAM-positive receptors: role of IL-12 and IL-18.

    abstract::Our previous studies have identified mechanisms by which cytokine production, blocked by Ly49G2 receptor cross-linking, can be overridden. In this study we analyzed the regulation of other ITAM-positive receptor signaling on NK, NKT, and T cells and characterized the biochemical pathways involved in this signaling. Ou...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-04-1579

    authors: Ortaldo JR,Winkler-Pickett R,Wigginton J,Horner M,Bere EW,Mason AT,Bhat N,Cherry J,Sanford M,Hodge DL,Young HA

    更新日期:2006-02-15 00:00:00

  • Polyclonal hematopoietic reconstitution in leukemia patients at remission after suppression of specific gene rearrangements.

    abstract::Clonality studies of hematopoietic reconstitution after remission were performed in 24 female patients (pts) with leukemias characterized by specific molecular markers. At diagnosis, 13 pts had promyelocytic leukemia (PML) retinoic acid receptor-alpha (RAR-alpha)-rearranged acute promyelocytic leukemia (APL), 8 Philad...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Lo Coco F,Pelicci PG,D'Adamo F,Diverio D,Alimena G,Montefusco E,Arcese W,Avvisati G,De Felice L,Meloni G

    更新日期:1993-07-15 00:00:00

  • Trogocytosis of multiple B-cell surface markers by CD22 targeting with epratuzumab.

    abstract::Epratuzumab, a humanized anti-CD22 antibody, is currently in clinical trials of B-cell lymphomas and autoimmune diseases, demonstrating therapeutic activity in non-Hodgkin lymphoma (NHL) and systemic lupus erythematosus (SLE). Thus, epratuzumab offers a promising option for CD22-targeted immunotherapy, yet its mechani...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2012-12-473744

    authors: Rossi EA,Goldenberg DM,Michel R,Rossi DL,Wallace DJ,Chang CH

    更新日期:2013-10-24 00:00:00

  • Kindlins in FERM adhesion.

    abstract::The Kindlin family of intracellular proteins has recently emerged as key regulators of cellular functions and cell-matrix interactions. The 3 members of this family, Kindlin-1, -2, and -3, perform an essential role in activation of integrin adhesion receptors, and expression of at least 1 Kindlin paralog is required t...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2009-10-239269

    authors: Malinin NL,Plow EF,Byzova TV

    更新日期:2010-05-20 00:00:00

  • Human neutrophils release the Leu-8 lymph node homing receptor during cell activation.

    abstract::The Leu-8 molecule, the human homologue of the murine MEL-14 peripheral lymph node homing receptor, is expressed on neutrophils in both species and may be important in localization of cells to sites of inflammation. Most circulating human neutrophils express the Leu-8 molecule, and activation of neutrophils with phorb...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Berg M,James SP

    更新日期:1990-12-01 00:00:00

  • Functional involvement of RINF, retinoid-inducible nuclear factor (CXXC5), in normal and tumoral human myelopoiesis.

    abstract::Retinoids triggers differentiation of acute promyelocytic leukemia (APL) blasts by transcriptional regulation of myeloid regulatory genes. Using a microarray approach, we have identified a novel retinoid-responsive gene (CXXC5) encoding a nuclear factor, retinoid-inducible nuclear factor (RINF), that contains a CXXC-t...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-07-170035

    authors: Pendino F,Nguyen E,Jonassen I,Dysvik B,Azouz A,Lanotte M,Ségal-Bendirdjian E,Lillehaug JR

    更新日期:2009-04-02 00:00:00